Skip to content

Researchers identify protein responsible for post-viral asthma in young children.

Researchers at the Medical College of Wisconsin (MCW) have linked a specific protein to the development of post-viral infection asthma, which is the first step in generating a novel type of asthma therapy designed to prevent development of post-viral asthma in young children.

Asthma is a chronic disease of the airways that affects more than 300 million people worldwide. It is the number one illness leading to school absences in children, and accounts for more than 1.8 million emergency room visits annually. There is no cure; all current therapies focus on providing symptomatic relief and reducing the number and severity of attacks.

Understanding the molecular mechanisms by which asthma develops and establishes itself as a chronic disease is key to elucidating alternative and potentially curative therapies state the team.  The researchers previously found evidence linking a human chemokine (protein) called CCL28 to the development of chronic asthma. This study is the first, however, that examines structural analysis and its impact on disease development.

The team found that even in the absence of a viral infection, CCL28 can play a role in the induction of asthma pathology, when the protein is natively folded. If unfolded, it does not.  The group propose that by exploiting the unique structural features of CCL28, potent and specific CCL28 inhibitors may be developed. This work is the first step in generating a novel type of asthma therapy that may have the power to prevent development of post-viral asthma in young children.

Source:  The Medical College of Wisconsin 

These two 3D CT volume rendered images show the vast distribution of the bronchial-pulmonary airway. The image on the left shows the bronchial pathways in relation to the whole lungs, and on the right the lungs are diminished to amplify the bronchial tree. Notice the distribution of the airways closely follows the vascular distribution of the lungs.  All Site Content ©2004-2015 CE Essentials, LLC; All Rights Reserved.
These two 3D CT volume rendered images show the vast distribution of the bronchial-pulmonary airway. The image on the left shows the bronchial pathways in relation to the whole lungs, and on the right the lungs are diminished to amplify the bronchial tree. Notice the distribution of the airways closely follows the vascular distribution of the lungs. All Site Content ©2004-2015 CE Essentials, LLC; All Rights Reserved.

Healthinnovations View All

Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.

Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.

Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.

Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.

Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.

An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.

Leave a Reply

Translate »